Ofir Levi

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ David Baker, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ofir Levi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vallon Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 30,000 $45,600 $1.52 14 May 2021 Direct

Insider Reports Filed by Ofir Levi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GRI Vallon Pharmaceuticals, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 16:08